ACETAZOLAMIDE SODIUM Drug Patent Profile
✉ Email this page to a colleague
When do Acetazolamide Sodium patents expire, and when can generic versions of Acetazolamide Sodium launch?
Acetazolamide Sodium is a drug marketed by Avet Lifesciences, Hikma, Hospira, Mylan Asi, Par Sterile Products, Xgen Pharms, and Zydus Pharms. and is included in seven NDAs.
The generic ingredient in ACETAZOLAMIDE SODIUM is acetazolamide sodium. There are ten drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the acetazolamide sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Acetazolamide Sodium
A generic version of ACETAZOLAMIDE SODIUM was approved as acetazolamide sodium by HIKMA on February 28th, 1995.
Summary for ACETAZOLAMIDE SODIUM
US Patents: | 0 |
Applicants: | 7 |
NDAs: | 7 |
Finished Product Suppliers / Packagers: | 7 |
Raw Ingredient (Bulk) Api Vendors: | 9 |
Clinical Trials: | 9 |
Patent Applications: | 143 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ACETAZOLAMIDE SODIUM at DailyMed |
Recent Clinical Trials for ACETAZOLAMIDE SODIUM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
The Leona M. and Harry B. Helmsley Charitable Trust | Phase 1/Phase 2 |
JDRF | Phase 1/Phase 2 |
University of California, San Diego | Phase 1/Phase 2 |
Pharmacology for ACETAZOLAMIDE SODIUM
Drug Class | Carbonic Anhydrase Inhibitor |
Mechanism of Action | Carbonic Anhydrase Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for ACETAZOLAMIDE SODIUM
US Patents and Regulatory Information for ACETAZOLAMIDE SODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Avet Lifesciences | ACETAZOLAMIDE SODIUM | acetazolamide sodium | INJECTABLE;INJECTION | 202693-001 | Dec 19, 2014 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Zydus Pharms | ACETAZOLAMIDE SODIUM | acetazolamide sodium | INJECTABLE;INJECTION | 206533-001 | Apr 15, 2019 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Mylan Asi | ACETAZOLAMIDE SODIUM | acetazolamide sodium | INJECTABLE;INJECTION | 200880-001 | May 9, 2012 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Hikma | ACETAZOLAMIDE SODIUM | acetazolamide sodium | INJECTABLE;INJECTION | 040089-001 | Feb 28, 1995 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |